Garry Watts, Non-Executive ChairmanGarry Watts joined the Group as Executive Chairman in 2011 before becoming NonExecutive Chairman between Admission and March 2016. He again served as Executive Chairman between March 2016 and June 2017 before resuming his Non-Executive Chairman role in July 2017. The Company does not consider Garry to be independent due to his previous executive role.
Current external appointments
Skills and previous experience
A chartered accountant by profession and former partner at KPMG, Garry’s extensive business knowledge and leadership on other listed company boards, including SSL International plc and Celltech Group plc, has ensured a seamless transition from private to public for the Company. He has a deep understanding of the healthcare sector having served as a member of the UK Medicines and Healthcare Products Regulatory Agency Supervisory Board for 17 years. Garry was also previously an executive director of Medeva plc, chairman of BTG plc, deputy chairman of Stagecoach Group plc and a non-executive director of Protherics plc.
Garry is a member of the Clinical Governance and Safety Committee and Nomination Committee.
*Garry will step down as a director of Foxtons Group plc in May 2020.